We are live on ! Find out more
BXRX

Baudax Bio, Inc. Common Stock
BXRX

Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

53 hedge funds and large institutions have $34.8M invested in Baudax Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Corsair Capital Management
New York
+$5.01M
2
BlackRock
BlackRock
New York
+$3.14M
3
ECM
Engine Capital Management
New York
+$2.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.31M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.77M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
1
Corsair Capital Management
New York
$5.68M +$5.01M +587 New
BlackRock
2
BlackRock
New York
$3.56M +$3.14M +368 New
ECM
3
Engine Capital Management
New York
$3.06M +$2.7M +316 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.62M +$2.31M +271 New
Renaissance Technologies
5
Renaissance Technologies
New York
$2.02M +$1.77M +208 New
NM
6
Newtyn Management
New York
$1.93M +$1.7M +199 New
NRC
7
North Run Capital
Massachusetts
$1.79M +$1.58M +185 New
PAM
8
Panagora Asset Management
Massachusetts
$1.35M +$1.19M +140 New
NRCM
9
Northern Right Capital Management
Connecticut
$1.32M +$1.16M +136 New
State Street
10
State Street
Massachusetts
$1.13M +$990K +116 New
Millennium Management
11
Millennium Management
New York
$1.08M +$956K +112 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$850K +$751K +88 New
N
13
Nuveen
North Carolina
$769K +$674K +79 New
Prudential Financial
14
Prudential Financial
New Jersey
$761K +$674K +79 New
Northern Trust
15
Northern Trust
Illinois
$707K +$623K +73 New
DCM
16
Driehaus Capital Management
Illinois
$685K +$606K +71 New
OAM
17
Oberweis Asset Management
Illinois
$557K +$495K +58 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$556K +$486K +57 New
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$522K +$461K +54 New
BGIM
20
Brandywine Global Investment Management
Pennsylvania
$459K +$427K +50 New
EIM
21
Essex Investment Management
Massachusetts
$417K +$367K +43 New
PPA
22
Parametric Portfolio Associates
Washington
$346K +$307K +36 New
JSL
23
JT Stratford LLC
Georgia
$296K +$265K +31 New
Citadel Advisors
24
Citadel Advisors
Florida
$198K +$171K +20 New
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$188K +$162K +19 New
1
2 3

BXRX Hedge Fund Activity: Q4 2019 in Review

53 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Baudax Bio, Inc. Common Stock (BXRX) for Q4 2019, worth a combined $34.8M.

Buyers outnumbered sellers: 53 funds opened new BXRX positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Corsair Capital Management, opening a new position worth an estimated $5.01M.

  • 53 institutional investors held Baudax Bio, Inc. Common Stock (BXRX) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $34.8M of Baudax Bio, Inc. Common Stock stock for Q4 2019.
  • 53 funds opened new Baudax Bio, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +53 holders.
  • The largest Baudax Bio, Inc. Common Stock buyer in Q4 2019 was Corsair Capital Management, an estimated $5.01M added.

Based on aggregated 13F filings for Q4 2019.